Cancer-specific Reference Values Established for PROMIS Domains

This study’s information can inform policy issues, particularly the collection of patient-reported outcome data and its use in clinical practice.

Reference values for the Patient-Reported Outcomes Measurement Information System (PROMIS) domains have been established by a population-based study published in the Journal of Clinical Oncology.1

Use of patient-reported outcomes (PROs) is increasing as endpoints in clinical trials. Reference values may improve the understanding of differences in specific cancer populations. The purpose of this study was to develop reference values of 8 PROMIS domains among patients.

According to the authors, “cancer-specific United States reference values enhance the understanding of the burden of cancer.” This information can inform policy issues, particularly the collection of PRO data and its use in clinical practice.

Want to read more?

CancerTherapyAdvisor.com is a free online resource that offers oncology healthcare professionals a comprehensive knowledge base of practical oncology information and clinical tools to assist in making the right decisions for their patients.

Our mission is to provide practice-focused clinical and drug information that is reflective of current and emerging principles of care that will help to inform oncology decisions.